株主・投資家の皆様へ

シェアホルダーサービス

アニュアルレポート
2019 Download
2018 Download
2017 Download
2016 Download
2015 Download
2014 Download
2013 Download
2012 Download
2011 Download
2010 Download

Top ten shareholders

as of 5/02/2020
Top 10 Shareholders Total Shares Owned Holding Percentage
Alvogen Emerging Markets Holdings Ltd. Representative: Thor Kristjansson 151,100,000 62.15%
Fuji Pharma Co., Ltd. 4,913,220 2.02%
Norges Bank 2,737,000 1.13%
Hontai Life Insurance Co.,Ltd. Representative: Huan I Lu 1,981,000 0.81%
JPMorgan Chase Bank N.A. Taipei Branch in custody for Vanguard Total International Stock Index Fund a series of Vanguard Star Funds 1,623,189 0.67%
Vanguard Emerging Markets Stock Index Fund a Series of Vanguard International Equity Index Funds 1,239,000 0.51%
Lungyen Life Service Corporation, Ltd. Representative: Wei Lung Liu 1,160,000 0.48%
Capital Small-And-Medium Cap Fund 1,100,000 0.45%
Yu feng Lin 1,051,000 0.43%
Credit Suisse Securities (Europe) Limited 972,000 0.40%

IRに関するお問い合わせ

代表

Bjartur Shen
Stratigies and Finance VP
電話:+886 2700 2 5908

営業、仕入れ係とクレームのコンタクト

電話:+886 2700 2 5908
Email:info@lotuspharm.com

代行

Angela Luan
Corporate Finance and Regional Investor Relations Director
電話:+886 2 2700 5908
Email: investor@lotuspharm.com

名義書換代理人

Yuanta Securities
Stock Affairs
Add:B1, No.210, Sec. 3, ChengDe Rd.,
Taipei City,
Taiwan
Tel: +886 2 2586 5859

薬害相談窓口

Tel: +886 2 2504 8125 Ext:1338/1339
Email: lotus.pv@alvogen.com